Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Researchers at Rensselaer Polytechnic Institute in the US have said that the commonly available, US Food and Drug Administration (FDA)-approved drug heparin could effectively neutralise SARS-CoV-2, the virus that causes Covid-19.
Based on research findings published in Antiviral Research, the drug may act as a decoy to prevent the virus from infecting human cells.
SARS-CoV-2 works by using a surface spike protein to attach to human cells and begin infection. However, heparin can bind with the surface spike protein to potentially block the infection.